Background: The p70 S6 kinase, an enzyme critical for cell-cycle progression through the G1 phase, is activated in vivo by insulin and mitogens through coordinate phosphorylation at multiple sites, regulated by signaling pathways, some of which depend on and some of which are independent of phosphoinositide 3-kinase (PI 3-kinase). It is not known which protein kinases phosphorylate and activate p70.
Background
The p70 S6 kinase is the enzyme in mammalian cells responsible for insulin-stimulated and mitogen-stimulated phosphorylation of the 40S ribosomal protein S6, which remains its only well-recognized substrate [1] . The two isoforms of the enzyme, denoted α1 and α2, are produced from a single gene by alternative mRNA splicing and the use of an alternative translational start site [2] . The 525 amino-acid p70α1 isoform differs from the 502 amino-acid p70α2 isoform only at the amino terminus (Figure 1) , where p70α1 contains a unique 23 amino-acid segment that encodes a polybasic nuclear-localization motif consisting of six consecutive arginine residues immediately after the initiator methionine residue (denoted MR 6 in Figure  1 ); this segment is also responsible for the aberrantly slow mobility of the α1 isoform upon SDS-polyacrylamide gel electrophoresis, so that p70α1 is sometimes called p85 S6 kinase. The cytosolic p70α2 isoform starts at a methionine residue equivalent to Met24 in p70α1, and the sequences of both isoforms are identical thereafter. The kinase is highly conserved in species from mammals to Drosophila [3, 4] , and its importance is indicated by the ability of antip70 antibodies, microinjected into REF52 cells, to arrest cell-cycle progression in G1 [5, 6] .
It has been long established that the p70 kinase is activated in vivo through phosphorylation of serine and/or threonine residues. The enzyme undergoes a multisite phosphorylation in response to stimulation by insulin or mitogens in vivo; the nuclear p70α1 and cytosolic p70α2 isoforms have identical sites of phosphorylation, and available data suggest that the mechanism of activation of the two proteins is identical. Treatment of the purified, active enzyme with protein (serine/threonine) phosphatase in vitro results in complete inactivation [7, 8] , but reactivation in vitro by phosphorylation has not been accomplished previously. It now appears likely that the difficulty in achieving reactivation arises in large part because p70 activation requires a complex array of separate, concurrent phosphorylations at multiple sites, catalyzed by several protein kinases.
Early work focused on a cluster of four or five serineproline or threonine-proline phosphorylation sites situated in a psuedosubstrate autoinhibitory domain in the p70 noncatalytic carboxy-terminal tail ( Figure 1) ; phosphorylation of these sites was predicted to release the p70 kinase from inhibition [9] . All of these residues are rapidly phosphorylated upon p70 activation [10] ; mutation of four of these serine/threonine residues to alanine reduces p70 activation in vivo by over 80%, whereas conversion to aspartate and glutamate produces a modest increase in basal p70 activity [11] . These serine-proline/threonine-proline sites can be phosphorylated in vitro by an array of proline-directed kinases that are activated by insulin or mitogen [12] ; such kinases include mitogen-activated protein (MAP) kinases, stress-activated protein (SAP) kinases and the cyclindependent kinase Cdc2; phosphorylation by these kinases, however, fails to reactivate phosphatase 2A-treated p70 S6 kinase [13] , indicating that phosphorylation of the p70 pseudosubstrate autoinhibitory domain, although perhaps necessary, is not sufficient for p70 activation.
A further indication that phosphorylation sites critical to p70 activation reside outside the p70 carboxy-terminal tail comes from the observation that a p70 truncation mutant lacking the entire carboxy-terminal tail (p70∆CT104), when stably expressed in NIH 3T3 cells, has a low basal activity in serum-deprived cells but undergoes a brisk, phosphorylation-dependent activation in response to serum that is nearly identical to that of the endogenous full-length p70 S6 kinase [14] . Like the wild-type fulllength p70, the activation of the p70∆CT104 truncation mutant is strongly inhibited by various phosphoinositide (PI) 3-kinase inhibitors. Moreover, transient co-expression of the p70∆CT104 mutant with a recombinant, constitutively active PI 3-kinase (p110*) produces a robust activation of p70∆CT104 S6 kinase activity that is not further augmented by serum. In contrast, the full-length p70 kinase is only partially activated by co-expression with PI 3-kinase, and it can be further activated by treatment of cells with serum. Rsk1, a protein kinase that is activated by Ras through MAP-kinase-catalyzed phosphorylation, is not activated at all by co-expression with PI 3-kinase [15] . These findings indicated that the full-length p70 requires both PI 3-kinase-dependent and PI 3-kinase-independent (possibly, Ras-dependent) signals for full activation, whereas the p70∆CT104 truncation mutant is dependent only on PI 3-kinase-regulated pathways.
As to the basis for the PI 3-kinase-induced activation of p70∆CT104, initial studies demonstrated that activation of p70∆CT104 was accompanied by a selective increase in the phosphorylation of Thr252, a residue that is situated in the activation loop of the p70 catalytic domain, homologous with sites of activating phosphorylation in many protein kinases. A threonine or a serine at this site is absolutely required for p70 activity, regardless of the presence of potentially activating mutations elsewhere. PI 3-kinase-stimulated phosphorylation of p70 at Thr252 is unimpaired in an inactive p70 ATP-site mutant, p70∆CT104 (Lys123→Met) and is therefore not catalyzed 70 Current Biology, Vol 8 No 2
Figure 1
Domain structure and phosphorylation sites of the p70 S6 kinase. Two p70 isoforms are known, α1 and α2 [2, 9] . The α1 isoform is used in all experiments presented in this paper. The single-letter amino-acid code is used. Pink, the canonical catalytic domain; blue, a 65 amino-acid segment that is similarly situated and conserved (about 40% identity) between p70, protein kinase C isoforms, PKBα and PKBβ, and the Rsk amino-terminal kinase domain [9] ; green, the amino-terminal and carboxy-terminal noncatalytic regions; red circles, sites of proline-directed phosphorylation. The approximate locations of 10 of the known p70 phosphorylation sites are shown and described in the text. The casein kinase 2 site at Ser40 does not influence catalytic function [14] and is not discussed further. The putative autoinhibitory psuedosubstrate domain extends from aminoacid 423 through to amino-acid 447 [9, 12] .
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LGFTYVAPSVLESVKEKFSFEP by a (cis) autophosphorylation. Thr252 phosphorylation is also not catalyzed directly by the PI 3-kinase. Nevertheless, Thr252 phosphorylation is inhibited by pretreatment of cells by the PI 3-kinase inhibitor wortmannin, indicating that this residue is a target in vivo for a 3-phosphoinositide-regulated protein kinase [15] .
Considerable evidence indicates that activation of p70∆CT104 is dependent on the phosphorylation of at least two sites in addition to Thr252, namely Thr412 and Ser394. Like Thr252, both Thr412 [11, 16] and Ser394 [17] are sites of mitogen-stimulated phosphorylation and are also phosphorylated in the inactive p70 S6 kinase (Lys123→Met) mutant in vivo; conversion of either residue to alanine ablates p70 activity. The phosphorylation of Thr412 and of Thr252 appear to be mutually interdependent in vivo; the Thr412→Ala mutant fails to undergo any detectable Thr252 phosphorylation in vivo, and Thr412 phosphorylation is greatly reduced, although still detectable in this mutant (Q.-P.W., M.T.K. and J.A., unpublished observations). Conversion of Thr412 to a glutamic acid results in an increase in basal p70 activity [16, 18] , restores fully the extent of p70 activation after mitogen treatment [16, 18] , and restores phosphorylation at Thr252 at least partially (Q.-P.W., M.T.K. and J.A., unpublished observations); the p70∆CT104 (Thr252→Ala, Thr412→Glu) double mutant is, nevertheless, inactive (Q.-P.W., M.T.K. and J.A., unpublished observations). Consequently, it is not clear from these data whether phosphorylation at Thr412 influences kinase activity directly, or through a necessary functional collaboration involving Thr252 phosphorylation, or entirely through the regulation of Thr252 phosphorylation. Moreover, although it appears clear that phosphorylation of both sites-or the substitution of a glutamate at residue 412 -is necessary to achieve p70 activation, it is unclear whether either alone is sufficient to sustain p70 activity.
Mutation of Ser394 to alanine also inactivates the p70 kinase [17] . This substitution has no significant effect on Thr252 phosphorylation, but it greatly diminishes Thr412 phosphorylation. Nevertheless, conversion of Thr412 to glutamate does not restore activity to the Ser394→Ala mutant, indicating that, like phosphorylation of Thr252 (and, perhaps, Thr412), Ser394 phosphorylation per se is required for p70 activity, quite apart from the effects of Ser394 phosphorylation on Thr412 phosphorylation and regardless of the state of Thr252 phosphorylation [17] . The properties of the Ser394→Ala mutant also establish that Thr252 phosphorylation can occur independent of Thr412 phosphorylation.
As regards the identity of the kinases that catalyze the phosphorylation of these three crucial sites, a pertinent observation is that the phosphorylation of Thr412, like that of Thr252, is increased by co-expression with activated PI 3-kinase (p110*) and inhibited by wortmannin. Both threonine residues are situated in relatively hydrophobic contexts (...VTHT 252 FCGT...; ...FLGFT 412 YVAP..., in the single-letter amino-acid code). Nevertheless, it is not clear whether these two threonine residues are phosphorylated by a single, or by two different, 3-phosphoinositide-dependent protein kinases. In contrast, Ser394, like the phosphorylation sites in the autoinhibitory psuedosubstrate domain, is followed directly by a proline residue and is likely to be phosphorylated by a proline-directed kinase distinct from the kinases acting on Thr252 and Thr412. In summary, although deletion of the p70 carboxy-terminal tail removes numerous phosphorylation sites, the activation of the p70∆CT104 truncation mutant nevertheless appears to require phosphorylation at (minimally) three sites, catalyzed by two or three different protein kinases.
We now describe the identification of one candidate activating-kinase for p70 S6 kinase; 3-phosphoinositidedependent protein kinase-1 (PDK1) is a recently identified protein (serine/threonine) kinase that contains a pleckstrin homology (PH) domain in its carboxy-terminal noncatalytic segment [19] . PDK1 was previously shown to activate in vitro protein kinase B (PKB, also known as cAkt) [19] , a PI 3-kinase-regulated protein kinase, through a phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 )-stimulated-phosphorylation of PKB at Ser308, a residue in the PKB activation loop that is homologous in location to Thr252 in p70 [20] . We show here that PDK1 also phosphorylates p70 in vitro within the activation loop, selectively at Thr252, resulting in activation of the p70 S6 kinase activity. PDK1-mediated phosphorylation and activation of p70 in vitro is independent of the presence of PtdIns(3,4,5)P 3 but is greatly influenced by the phosphorylation state of the p70 noncatalytic carboxy-terminal tail, and by a negative charge at Thr412 of p70. These data provide strong direct support for the importance of Thr252 in p70 activation, and reveal the highly synergistic interaction between Thr252 and Thr412 in p70 activation. In addition, they point to a multifunctional role for PDK1 in signal transduction downstream of PI 3-kinase, and to a model for the regulation of PDK1 in vivo by control of its cellular localization and by substrate-directed mechanisms.
Results

PDK1 activates p70 S6 kinase upon cotransfection
The p70 mutant p70∆CT104 lacks the carboxy-terminal 104 amino acids but, like full-length p70, has a low activity in serum-deprived cells which is rapidly activated by insulin or mitogens (Figure 2 ), and is inhibited by submicromolar concentrations of wortmannin and rapamycin [14, 18] . The similarity in the regulatory responses of p70∆CT104 to those of the full-length p70, despite removal of a segment that contains numerous serine/threonine residues whose phosphorylation is necessary for activation of the full-length p70, has led us to use the truncation mutant to evaluate the ability of candidate kinases to activate p70 kinase. Consistent with earlier findings [15] , co-expression of p70∆CT104 with a recombinant, constitutively active PI 3-kinase (p110*) in CHO-IR cells resulted in a robust activation of p70∆CT104, which was not further augmented by pretreatment of the cells with insulin. Similarly, co-expression with PDK1 induced comparable activation of p70∆CT104 to that seen with p110*. PDK1 also activated full-length p70 on co-expression (Figure 2b ), although the extent of activation was more modest than that observed with p70∆CT104, and could be further augmented by pretreatment with insulin. Persistent insulin-responsiveness of full-length p70 has also been observed after co-expression with p110* [15] and has been suggested to reflect a requirement for PI 3-kinaseindependent inputs that are eliminated by deletion of the carboxy-terminal tail.
Burgering and Coffer [21] reported that co-expression of full-length p70 with a constitutively active form of PKB (gag-PKB) resulted in activation of p70 S6 kinase activity in vivo. We found that PKB, and especially gag-PKB, gave substantial activation of p70∆CT104 (Figure 2c ). Alessi et al. [19] recently demonstrated that PDK1 can activate PKB both in vivo, upon co-expression, as well as in vitro, by direct phosphorylation of Thr308 in the PKB activation loop; consequently, the ability of PDK1 to activate p70 when co-expressed might be attributable to PDK-induced activation of endogenous PKB. We therefore examined the ability of recombinant PKB and PDK1 to phosphorylate and activate p70 S6 kinase directly in vitro.
Expression of GST-p70∆CT104 and its phosphorylation by PDK1
The cDNA encoding p70∆CT104 was fused in-frame with the carboxyl terminus of glutathione S-transferase (GST) in the vector pEBG [22] . GST-p70∆CT104 was expressed in human embryonic kidney 293 cells and purified on glutathione-Sepharose beads. The preparation showed a major Coomassie blue-stained band of apparent molecular mass 83 kDa, corresponding to GST-p70∆CT104 fusion protein ( Figure 3 ). The purity, estimated by densitometric analysis of the gels, was more than 80%, and 2 mg purified GST-p70∆CT104 protein was obtained from forty dishes (10 cm diameter) of 293 cells. The GST-p70∆CT104 fusion protein purified from unstimulated 293 cells had a low activity (0.7 U/mg), but, like the parent p70∆CT104, it was activated 4-10-fold in response to stimulation with insulin or mitogen. (See Materials and methods for the definition of a unit.)
As reported previously [19] , PDK1 expressed as a GSTfusion protein (GST-PDK1) in 293 cells phosphorylated GST-PKBα only in the presence of lipid vesicles containing 10 µM PtdIns(3,4,5)P 3 ( Figure 4a ). Interestingly, under identical conditions, GST-PDK1 also phosphorylated GST-p70∆CT104, but this phosphorylation was not dependent on the presence of lipid vesicles containing PDK1 activates p70 S6 kinase during transient expression. CHO-IR cells were transfected with plasmids encoding hemagglutin (HA)-tagged HA-p70α1 full-length (b) or HA-p70∆CT104 (a,c), together with pCMV5 vector (see Materials and methods) or pCMV5 plasmid encoding PDK1, or p110*, PKB or gag-PKB, as indicated. After 48 h, the cells were transferred to serum-free medium and 16 h later, insulin (I, 10 -7 M) or carrier (B) was added. After 20 min, the cells were rinsed in ice-cold PBS and extracted into ice-cold lysis buffer [14] ; aliquots matched for protein amounts were immunoprecipitated with the anti-HA monoclonal antibody 12CA5. Washed immunoprecipitates were assayed for 40 S kinase activity [14, 15] ; the assays were terminated with SDS and subjected to SDS-PAGE and transferred to a polyvinylidene difluoride membrane. After autoradiography, an anti-p70 peptide antibody was used for immunoblot of the HA-p70 proteins [2] . Radioactive phosphate ( 32 P) incorporated into S6 is indicated as c.p.m. beneath the corresponding S6 band. Mock transfections were cells treated with lipofectamine but no plasmid DNA. increased the specific activity of GST-p70∆CT104 three-to four-fold, to approximately 2 U/mg ( Figure 4c ). As with PDK1-catalyzed phosphorylation of GST-p70∆CT104, the activation of GST-p70∆CT104 by GST-PDK1 was also unaltered by the presence of PtdIns(3,4,5)P 3 , whereas, in parallel incubations, the activation of GST-PKBα by GST-PDK1 was completely dependent on the presence of this 3-phosphoinositide in the assay ( Figure 4b ). PDK1 purified from rabbit skeletal muscle also phosphorylated and activated GST-p70∆CT104 independently of PtdIns(3,4,5)P 3 and to a similar extent as did recombinant GST-PDK1 (data not shown).
In contrast to the readily evident phosphorylation of GST-p70∆CT104 catalyzed by GST-PDK1, active GST-PKBα derived from 293 cells stimulated with insulin-like growth factor-1 (IGF-1) [23] was not able to phosphorylate GST-p70∆CT104 in vitro (Figure 4d ). The activity of the recombinant PKB was demonstrated by its ability to phosphorylate histone H2B. (Figure 4d ). Thus, it appears that, whereas PDK1 directly phosphorylates and activates both PKB and p70 in vitro, PKB lacks direct p70 kinase-kinase activity. In addition, p70 does not contain the PKB consensus sequence for phosphorylation, namely Arg-X-Arg-X-X-Ser/Thr-Hyd, where X is any amino acid and Hyd is a large hydrophobic residue [24] .
PDK1 phosphorylates Thr252 of p70 S6 kinase
The GST-p70∆CT104 fusion protein was phosphorylated to 0.25 mole phosphate per mole protein by GST-PDK1, digested with trypsin, and the resulting peptides were chromatographed on a C 18 column at pH 1.9. Only one major 32 P-labelled tryptic peptide (termed P1), eluting at 31% acetonitrile was observed ( Figure 5a ). The peptide digests contained phosphothreonine only (data not shown); the sequence of the 32 P-labelled tryptic peptide commenced at residue 242 of p70 S6 kinase and a single burst of radioactivity was released after the eleventh cycle of Edman degradation ( Figure 5c ). This finding establishes that PDK1 phosphorylated GST-p70∆CT104 at Thr252, which lies nine residues upstream of the subdomain VIII of the catalytic domain [9] . This conclusion is further supported by the inability of GST-PDK1 to catalyze significant phosphorylation of the inactive mutant, p70∆CT104 (Thr252→Ala) (Figures 5b,6b) . Predictably, the amino-acid residues surrounding Thr252 of p70 S6 kinase are highly homologous to those found surrounding Thr308 of PKBα [19] . PDK1 purified from rabbit skeletal muscle also phosphorylated Thr252 of p70 S6 kinase (data not shown).
The role of the p70 carboxy-terminal tail
To characterize the phosphorylation of p70 S6 kinase by PDK1 further, we compared the phosphorylation and activation of a variety of p70 S6 kinase mutants following incubation with both high (9 nM) and low (0.9 nM) concentrations of GST-PDK1. All of the GST-p70 S6 kinase mutants were expressed in 293 cells, purified by affinity chromatography on glutathione-Sepharose and found to be more than 80% homogenous as judged by SDS-polyacrylamide gel electrophoresis (Figure 3) . A catalytically inactive ATP-site mutant (Lys123→Met) of GST-p70∆CT104 was phosphorylated by GST-PDK1 at Research Paper PDK1 activates p70 S6 kinase Alessi et al. 73
Figure 3
SDS-polyacrylamide gel of purified GST-p70 S6 kinase fusion proteins. Human embryonic kidney 293 cells were transiently transfected with the pEBG DNA constructs (see Materials and methods) expressing the wild-type and mutant forms of GST-p70 S6 kinase. After 24 h, the cells were deprived of serum for 16 h, washed, extracted into Buffer A (see Materials and methods), and the GST-p70 S6 kinase proteins were purified by affinity chromatography on glutathione-Sepharose. An aliquot (2 µg) of the glutathione-Sepharose eluate was subjected to electrophoresis on a 10% SDS-polyacrylamide gel, which was stained with Coomassie blue. Lane Current Biology about one half the rate of the active GST-p70∆CT104 mutant, but, as expected, the negligible activity of the ATP-site mutant was not thereby altered (Figure 6a,b) .
To examine the influence of the p70 carboxy-terminal tail on PDK1-catalyzed p70 phosphorylation and activation, we made a full-length p70 mutant in which five residues (Ser434, Ser441, Thr444, Ser447, Ser452), which correspond to phosphorylation sites in the autoinhibitory psuedosubstrate domain of the carboxy-terminal tail, were changed to alanine (GST-p70 (5Ala)). The GST-p70 fulllength and the GST-p70∆CT104 fusion proteins had very similar basal activities after purification from 293 cells, whereas the GST-p70 (5Ala) mutant had a basal specific activity that was almost 90% lower ( Figure 6a ). When the three GST-p70 fusion proteins were adjusted to the same concentration and phosphorylated by GST-PDK1, each was found to have some increase in S6 kinase activity (Figure 6b ). The GST-p70 (5Ala) mutant was phosphorylated by 9 nM GST-PDK1 to half the extent of the GST-p70 full-length protein and one fifth the extent of GST-p70∆CT104. The absolute increase in S6 kinase activity of GST-p70 (5Ala) was one half to one third that of the GST-p70 full-length protein, and less than 10% that of GST-p70∆CT104. The GST-p70∆CT104 protein was phosphorylated by 0.9 nM GST-PDK1 at a five-fold higher initial rate, and by 9 nM GST-PDK1 to a two-to three-fold greater extent than was the GST-p70 fulllength protein (Figure 6b) . Moreover, the absolute increase in S6 kinase activity of GST-p70∆CT104 was nearly five-fold greater when compared to the GST-p70 full-length protein (Figure 6a ). These data show that the carboxy-terminal tail controls both the access of PDK1 to Thr252 and the extent of p70 activation achieved by any level of PDK1-catalyzed Thr252 phosphorylation. The second point is demonstrated by the observation that 9 nM GST-PDK1 catalyzed Thr252 phosphorylation of the fulllength GST-p70 (5Ala) and full-length, unmodified GST-p70 to 0.07 and 0.14 moles phosphate per mole protein, respectively ( Phosphorylation and activation of GST-PKBα and GST-p70∆CT104 by PDK1. GST-PKBα or GST-p70∆CT104 was incubated for 30 min at 30°C with Mg-[γ-32 P]ATP in the presence or absence of GST-PDK1 (9 nM) and phospholipid vesicles containing 100 µM phosphatidylcholine, 100 µM phosphatidylserine, and 10 µM D-enantiomer of sn-1-stearoyl, 2-arachidonyl PtdIns(3,4,5)P 3 . (a) The reactions were terminated by making the solutions 1% in SDS, the samples were subjected to SDS-PAGE, and the phosphorylation was assessed by autoradiography of the gel. The Coomassie blue-stained band corresponding to GST-PKBα or GST-p70∆CT104 is indicated with an arrow. (b) The increase in specific activity of GST-PKBα (U/mg) was determined, relative to a control incubation in which GST-PDK1 was omitted. The basal activity of GST-PKBα was 2. of amino acids 2-46 resulted in a marked decrease in p70 specific activity, which was reversed if the p70 carboxyterminal tail was also deleted [14, 18] . This pattern, previously observed with HA-tagged p70 proteins, is also evident with GST-p70 fusion proteins ( Figure 6c ). As shown in Figure 6d , PDK1 was not able to phosphorylate Thr252 in the GST-p70∆2-46 truncation mutant; concomitant deletion of the carboxy-terminal tail (GSTp70∆2-46/∆CT104) not only increased the specific activity of the enzyme when isolated from 293 cells, but also restored the ability of PDK1 to phosphorylate the p70 protein in vitro and thereby activate the S6 kinase.
The role of Thr412
A Thr412→Ala mutation of GST-p70∆CT104 reduced the basal level of activity more than 10-fold ( Figure 6a ). GST-p70∆CT104 (Thr412→Ala) was phosphorylated by GST-PDK1 at a two-to three-fold higher rate than was GST-p70∆CT104, and to a maximal stoichiometry of 0.8 moles phosphate per mole protein, resulting in a fivefold activation. Nevertheless, the specific activity of Thr252-phosphorylated-GST-p70∆CT104 (Thr412→Ala) remained at 10% that of the less extensively phosphorylated GST-p70∆CT104 (about 0.3 moles phosphate per mole protein; Figure 6a) . A GST-p70∆CT104 fusion protein in which Thr412 was mutated to glutamate had a basal level of activity that was about 20-fold higher than that of the unmodified GST-p70∆CT104 protein ( Figure  6a ). Phosphorylation of GST-p70∆CT104 (Thr412→Glu) with 9 nM GST-PDK1 resulted in a further three-fold activation of this enzyme to a specific activity of nearly 50 U/mg, with a concomitant increase in phosphorylation to a stoichiometry of 0.9 moles phosphate per mole protein (Figure 6a,b) . Thus, PDK1 phosphorylates Thr252 regardless of whether residue 412 is a threonine, alanine or glutamate, (although much more readily in the case of the latter two variants) and activates each variant to a similar relative extent (about three-to four-fold). The absolute extent of activation, however, is dependent on the initial specific activity. This feature led us to investigate whether the very high initial specific activity of GST-p70∆CT104 (Thr412→Glu) is attributable directly to the presence of a negative charge at residue 412, or whether mutations at Thr412 alter the phosphorylation of other potentially activating residues in vivo.
In fact, treatment in vitro of GST-p70∆CT104 and GST-p70∆CT104 (Thr412→Glu), isolated from serumdeprived cells, with a high concentration of protein phosphatase 2A 1 (PP2A 1 ) resulted in a profound decrease in S6 kinase activity. The decrease was 80% (to 0.15 U/mg) for GST-p70∆CT104 ( Figure 7a ) and 90-95% (to approximately 1.0 U/mg) for GST-p70∆CT104 (Thr412→Glu) (Figure 7c ). Phosphorylation of PP2A 1 -treated GSTp70∆CT104 with GST-PDK1 and Mg-ATP resulted in a marked activation of GST-p70∆CT104, about 15-fold, to a specific activity of 2.2 U/mg (Figure 7a ). The time course of GST-PDK1-catalyzed phosphorylation of PP2A 1 -treated and untreated GST-p70∆CT104 was identical, with both reaching plateau phosphorylation at about
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Figure 5
PDK1 phosphorylates Thr252 of p70 S6 kinase. (a) GST-p70∆CT104 or (b) GST-p70∆CT104 (Thr252→Ala) was maximally phosphorylated by incubation with GST-PDK1 (9 nM) and Mg-[γ-32 P]ATP (100 µM) for 1 h at 30°C, alkylated with 4-vinylpyridine and digested with trypsin. The digest was applied to Vydac 218TP54C 18 column (Separations Group) equilibrated in 0.1% (v/v) trifluoroacetic acid in water. The column was developed with a linear acetonitrile gradient (diagonal line) at a flow rate of 0.8 ml/min and fractions of 0.4 ml were collected. (a) 65% of the radioactivity applied to the column was recovered in the major 32 Pcontaining peptide eluting at 31% acetonitrile, designated P1; the remainder of the radioactivity eluted as numerous minor peaks. (c) A portion of the P1 sample (10 pmol) was analyzed on an Applied Biosystems 476A sequencer to determine the amino-acid sequence, and the phenylthiohydantoin (Pth) amino acids identified after each cycle of Edman degradation on the sequencer (shown under the chart, using the single-letter code for amino acids). To identify the site(s) phosphorylated on P1, another aliquot (900 c.p.m.) was subjected to one cycle of Edman degradation on the sequencer to remove the aminoterminal glutamate [28] and the resulting peptide was then coupled covalently to a Sequelon arylamine membrane and analyzed on the sequencer using the modified program described in [28] . Radioactivity ( 32 P) released was measured after each cycle of Edman degradation. (Figure 7b ). Phosphorylation of the PP2A 1 -treated GST-p70∆CT104 (Thr412→Glu) by PDK1 and Mg-ATP resulted in a 30-40-fold activation and restored the activity of PP2A 1 -treated GST-p70∆CT104 (Thr412→Glu) to 80-90% of that achieved by PDK1 phosphorylation of the GST-p70∆CT104 (Thr412→Glu) protein which had not been pretreated with PP2A 1 (Figure 7c) . Estimation of the extent of phosphorylation of GST-p70∆CT104 (Thr412→Glu) by PDK1 is somewhat confounded by the occurrence of autophosphorylation, which is reduced substantially by pretreatment with PP2A 1 . Nevertheless, the autophosphorylation of GST-p70∆CT104 does not seem to lead to activation (Figure 7c,d ). Correcting approximately for this autophosphorylation, it appears that PP2A 1 pretreatment of GST-p70∆CT104 (Thr412→Glu) does not significantly alter the extent of subsequent phosphorylation by GST-PDK1.
The role of Ser394
Ser394 is a site of mitogen-stimulated phosphorylation in vivo, and mutation of this residue to alanine diminishes p70 activity by about 90% [17] . Although PDK1-catalyzed phosphorylation of p70∆CT104 (Ser394→Ala) was reduced somewhat when compared to that of p70∆CT104, a more significant factor is that phosphorylation at Thr252 in the p70∆CT104 (Ser394→Ala) mutant was much less effective in increasing S6 kinase activity, which remained 15-20% of that achieved with p70∆CT104 (Figure 6c,d) . Conversion of Ser394 to aspartate did not result in increased PDK1-catalyzed Thr252 phosphorylation, but restored S6 kinase activity to levels at least 50% of the activity of p70∆CT104 (Thr412→Glu) when phosphorylated at Thr252 to a comparable extent. The impact of the Ser394→Ala mutation on S6 kinase activity could be an indirect one, inasmuch as the Ser394→Ala mutation has been observed to substantially diminish Thr412 phosphorylation in vivo [17] . Nevertheless, it appears that phosphorylation of Ser394 is required for substantial S6 kinase activity, independent of the phosphorylation state of Thr252.
Discussion
The results presented here demonstrate that PDK1, the kinase that activates PKB in vitro in a PtdIns(3,4,5)P 3 -dependent manner by phosphorylating Ser308 in the PKB activation loop [19] , also activates p70 S6 kinase through phosphorylation at a homologous site, Thr252. This finding establishes that the insulin-stimulated and mitogen-stimulated, PI 3-kinase-directed phosphorylation of p70 at Thr252 that occurs in vivo is a critical component of the activation of p70 in vivo. Moreover, the ability of PDK1 to phosphorylate Thr252 selectively in vitro has enabled an informative analysis of the contributions of other p70 domains and phosphorylation sites to the activation process.
The p70 carboxy-terminal tail encodes a psuedosubstrate autoinhibitory domain, which in its unphosphorylated state was predicted to be important to maintaining the low basal activity of the enzyme [9] . The data presented here demonstrate that the carboxy-terminal tail may suppress p70 activity by at least two mechanisms. First, the carboxyterminal tail, particularly when not phosphorylated (as in the 5 Ala substituted form), restricts the ability of PDK1 to phosphorylate Thr252 in vitro, and probably serves a similar function in vivo. This 'gating' function is controlled both by the phosphorylation of the multiple serine-proline and threonine-proline residues clustered in the autoinhibitory psuedosubstrate domain and by a contribution from the p70 amino-terminal noncatalytic segment, amino acids 2-46 (or more specifically, amino acids 29-46 [14] ). The p70∆2-46 mutant, although exhibiting unimpaired phosphorylation of the carboxy-terminal tail in vivo [14, 18] , has a very low activity in vivo and is unable to undergo PDK1-catalyzed phosphorylation in vitro; the p70∆2-46 mutant is also severely deficient in the phosphorylation of Thr412 in vivo ( [18] , Q.-P.W., M.T.K., and J.A., unpublished observations). Whether the failure of PDK1 to catalyze Thr252 phosphorylation in vitro is due to a lack of displacement of the carboxy-terminal tail, or the absence of Thr412 phosphorylation, cannot therefore be unequivocally determined. Nevertheless, all these defects are reversed by further deletion of the carboxy-terminal
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Figure 7
Effect of dephosphorylation on the activity of GST-p70∆CT104 and GST-p70∆CT104 (Thr412→Glu) and their subsequent phosphorylation and activation by PDK1. tail. Whether the input provided by the amino acid 2-46 segment is subject to regulation is not known, although it should be mentioned that deletion of this segment also abrogates p70 inhibition by rapamycin [14] .
A second function of the carboxy-terminal tail, independent of its ability to gate access of p70 kinase-kinases to sites whose phosphorylation is critical for p70 kinase activation, is the ability of the nonphosphorylated tail to suppress the extent of increase in p70 catalytic activity produced by any level of Thr252 phosphorylation. This may reflect the ability of the nonphosphorylated psuedosubstrate autoinhibitory domain to bind to, and to occlude, the substrate-binding site; alternatively, or in addition, the nonphosphorylated tail may interfere with the synergistic interaction between the phosphorylated Thr252 and Thr412 residues.
The importance of the residue 412 of p70 to activation of the p70 kinase is clearly shown by these studies, and the basis for its function is uncovered, at least in part. One important function of Thr412 is indicated by the increased extent in vitro of PDK1-catalyzed Thr252 phosphorylation in the p70∆CT104 mutant that results when Thr412 is replaced by either an alanine or a glutamate. This suggests that Thr412, presumably in its unphosphorylated state, restricts the phosphorylation of p70∆CT104 at Thr252 in vitro. In vivo, however, replacement of Thr412 by alanine or glutamate in full-length p70 abolishes, or greatly diminishes, respectively, Thr252 phosphorylation. Thus, Thr412 phosphorylation in full-length p70 may be required to dislodge the carboxy-terminal tail and make Thr252 available; deletion of the carboxy-terminal tail eliminates this function and uncovers the restricting effect of Thr412.
Apart from the role of Thr412 in regulating the phosphorylation of Thr252, the data presented here establish the potent functional synergy between the phosphorylation of Thr252 and that of Thr412 in the activation of p70 S6 kinase. Earlier studies did not resolve whether the low activity of the Thr412→Ala mutant is attributable to the absence of a negative charge at residue 412, or to the resultant failure of Thr252 to undergo phosphorylation in vivo. PDK1 is able to phosphorylate Thr252 in the GSTp70∆CT104 (Thr412→Ala) mutant in vitro, to an extent far exceeding that achieved for GST-p70∆CT104. Nevertheless, although the normally very low basal activity of GST-p70∆CT104 (Thr412→Ala) is thereby increased five-fold, its maximal activity remains no more than 10% that of the far less extensively Thr252-phosphorylated GST-p70∆CT104 parent. Thus, nearly stoichiometric phosphorylation of Thr252 alone is insufficient to give substantial p70 activity.
Reciprocally, the very high basal activity of the GST-p70∆CT104 (Thr412→Glu) mutant can be reduced to very low levels by treatment with PP2A 1 (Figure 7c ), demonstrating that a negative charge at every residue 412 by itself is insufficient to give more than a small percentage of the maximal p70 activity. Nevertheless, phosphorylation of the PP2A 1 -treated GST-p70∆CT104 (Thr412→Glu) by PDK1 selectively at Thr252, to a stoichiometry of about 0.5 moles phosphate per mole protein (Figure 7d ), results in a 30-40-fold activation (Figure 7c ), revealing the remarkably synergistic functional interaction between phosphorylated Thr252 and Glu412 (and, presumably, phosphorylated Thr412 in the wild-type enzyme). Thus, although we do not know the extent of Thr252 phosphorylation in GST-p70∆CT104 (Thr412→Glu) as compared to GSTp70∆CT104 (or the extent of Thr412 phosphorylation in the latter), it appears likely that the presence of a glutamate at each residue 412 will ensure that every phosphorylated Thr252 residue participates in an activating conformation.
The p70 Thr412 residue is situated in a hydrophobic segment within a 65 amino-acid domain that is positioned immediately carboxy-terminal to the canonical catalytic domain [9] . This carboxy-terminal extension of the catalytic domain is homologous (about 40% sequence identity) to similarly located domains found in the PKCs, PKBα and PKBβ, and the Rsk amino-terminal kinase domain [9] . Moreover, each of these kinases contains, within this domain, sites of phosphorylation that are homologous to p70 Thr412 in both location and sequence context and are critical to activation of the respective kinase -for example, the PKB Ser473 residue, which together with PKB Thr308 (homologous to p70 Thr252), is concurrently phosphorylated in vivo in an insulin-stimulated, wortmannin-inhibited fashion [20] . The synergistic activation of PKB by site-specific phosphorylation in the activation loop and in the carboxy-terminal extension of the catalytic domain is closely analogous to that of GST-p70∆CT104. Although PDK1 can phosphorylate both PKB Ser308 and p70 Thr252 effectively in vitro, the phosphoinositide-regulated kinases that act on p70 Thr412 and PKB Ser473 remain to be identified.
The role of Ser394 phosphorylation in the PDK1-mediated activation of GST-p70∆CT104 is different from that of Thr412; although phosphorylation of Ser394 appears to be crucial for maintaining the S6 kinase activity at levels greater than 20% those of the wild-type enzyme, no evidence of a functional interaction between Ser394 and either Thr252 or Thr412 is evident. Thus, the phosphorylation/dephosphorylation of Ser394 provides a third level of regulation, independent of the interacting inputs directed at Thr252 and Thr412. Ser394 is followed immediately by a proline residue, as in the multiple sites residing in the autoinhibitory psuedosubstrate domain in the carboxyl terminus. It is not known, however, whether Ser394 is phosphorylated by the same proline-directed kinases that act on the p70 carboxy-terminal tail [13] .
Ser394 is located in the equivalent position to the Thr450 residue of PKB, which is also followed immediately by a proline and is phosphorylated in vivo. PKB Thr450 phosphorylation is, however, not stimulated by insulin or IGF-1 [20] .
The ability of PDK1 to phosphorylate p70 Thr252 and to activate the p70 S6 kinase activity in vitro raises the question of whether PDK1 is the enzyme responsible for the PI 3-kinase-dependent phosphorylation of p70 Thr252 in response to stimulation by insulin and mitogen, as has been proposed for PKB Ser308. Notably, although 3-phosphoinositides greatly increase the rate of PDK1 phosphorylation of PKB in vitro, PDK1 phosphorylates GSTp70∆CT104 at a comparably high rate in the absence of PtdIns(3,4,5)P 3 , and addition of these lipids to the assay does not alter the rate of PDK1-catalyzed p70 phosphorylation or activation (Figure 4) . The relatively high, PtdIns(3,4,5)P 3 -independent (GST-p70∆CT104) kinase activity exhibited in vitro by recombinant GST-PDK1 purified from serum-deprived cells raises the question of whether PDK1 is a plausible candidate p70 kinase in vivo; the related question is whether, and by what means, PDK1 activity is regulated in vivo. Treatment of cells with insulin or IGF-1, which results in a 20-40-fold increase in the activity of PKB [20] , does not alter the ability of endogenous or recombinant PDK1 to phosphorylate PKB in vitro, either in the presence or the absence of PtdIns(3,4,5)P 3 [19] . Thus, although PtdIns(3,4,5)P 3 does bind to PDK-1 with high affinity (R. Currie, C.P. Downes and D.R.A., unpublished observations), the lipid does not appear to stimulate the catalytic activity of purified or recombinant PDK1. Previous work has established that a dominant part of the ability of PtdIns(3,4,5)P 3 to stimulate PDK1-catalyzed PKB phosphorylation is attributable to the binding of the lipid to the PKB substrate, thereby making PKB Ser308 accessible to PDK1 [19] . Thus, the marked PtdIns(3,4,5)P 3 dependence of PDK1-catalyzed PKB activation in vitro probably reflects the binding of both PDK1 and PKB to the lipid vesicles, thereby promoting their contiguity, together with a PtdIns(3,4,5)P 3 -induced alteration in PKB conformation, which promotes the availability of PKB Ser308 to phosphorylation by PDK1.
A likely situation in the cell is that PDK1 is constitutively active but unable to access p70 Thr252, because this residue is sequestered within the p70 structure in the conformation specified by the dephosphorylated Thr412 and by the unphosphorylated p70 carboxy-terminal tail (Figure 8 ). Moreover, in view of the marked site-site
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Figure 8
A model for the activation of the p70 S6 kinase in response to insulin and mitogens. The process is divided into four steps.
Step 1 involves the action of an array of prolinedirected kinases, including the Rasdependent activation of MAP kinases, SAP kinases, p38s, and Cdc2 [12] , which phosphorylate the p70 carboxy-terminal tail (Ser434, Ser441, Thr444, Ser447, and Ser452), and perhaps Ser394 in the carboxy-terminal extension of the catalytic domain. PI 3-kinase, when activated strongly, may activate Ras sufficiently to engage this step; strong activation of Ras may also activate the PI 3-kinase. The broken arrow indicates the possibility that PI 3-kinase may activate proline-directed kinases independently of Ras, for example, through the Rho family of GTPases.
Step 2 involves the release of the phosphorylated carboxyterminal tail of p70 from the catalytic domain, providing access to Thr412 and Thr252. The existence of this step is inferred from the ability of the ∆2-46 deletion to interrupt p70 activation at this point; whether this step is regulated is not known.
Step 3 involves the phosphorylation of Thr412 by a PtdIns(3,4,5)P 3 -dependent kinase. This alone produces only a slight activation of S6 kinase activity, but facilitates access to Thr252 and sets up the conformation necessary for a concerted activation.
Step 4 involves PDK1-catalyzed phosphorylation of Thr252, resulting in full activation of the S6 kinase, due to the strong positive cooperativity between the phosphorylated Thr412 and Thr252 residues. Inactivation may be achieved by dephosphorylation at either site. Steps 3 and 4 probably occur in a concerted fashion, because all of the components (Thr412 kinase, PDK1 and p70) are probably assembled close together through the mediation of PtdIns(3,4,5)P 3 . PKC isoforms may also contribute in part to the activation of p70 by mitogen but the steps that are facilitated and the elements employed are not known. Similarly, the role of the target of rapamycin in mammalian cells, mTOR, in p70 regulation is not addressed by the data presented.
P P P P P P P P P P P P P P P P P P P P P P P P P P P interaction required for p70 activation, any phosphorylation of p70 Thr252 that occurs in the absence of concomitant (3-phosphoinositide stimulated) p70 Thr412 phosphorylation is unlikely to generate significant p70 activation in vivo. Thus, our model for the activation of the p70 S6 kinase by insulin and mitogens (Figure 8) proposes that the initial step is Ras-directed phosphorylation of the p70 carboxy-terminal tail, catalyzed by proline-directed mitogen-activated kinases [13] , distinct from PDK1 and from the Thr412 kinase; this enhances the accessibility of Thr252 (and perhaps Thr412). Activation of PI 3-kinase and the synthesis of 3-phosphoinositides recruits PDK1 to the membrane and probably the 3-phosphoinositidedependent Thr412 kinase as well. Phosphorylation at Thr412, by the as yet unidentified PtdIns(3,4,5)P 3 -regulated protein kinase(s), further facilitates PDK1-catalyzed Thr252 phosphorylation. The concurrent phosphorylation of Thr412 and Thr252 results in the strong positively cooperative site-site interaction that is the dominant factor in p70 activation. Thus, phosphorylation and disengagement of the p70 carboxy-terminal tail, together with phosphorylation of p70 Thr412, enables access of PDK1 to the p70 activation loop, much as binding of phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P 2 ) to the PKB PH domain facilitates access of PDK1 to the PKB activation loop. We suggest that regulation of PDK1 by the PI 3-kinase is indirect -it is not achieved by an increase in PDK1-intrinsic specific activity, but by an enhanced accessibility of its target sites and by the regulation of its intracellular localization through the interaction with phosphoinositides. This model implies that a mechanism must exist to recruit p70 to the vicinity of these PtdIns(3,4,5)P 3 -associated kinases, perhaps through the interaction of p70 with small GTPases of the Rho subfamily [25] .
Materials and methods
Materials and buffer solutions
The D enantiomer sn-1-stearoyl-2-arachidonyl PtdIns(3,4,5)P 3 was a gift from P. Gaffney and GST-PKBα was prepared as described [23] .
The peptides used to assay PKBα, (RPRAATF) [24] and p70 S6 kinase (KKRNRTLTV) [26] and TTYADFIASGRTGRRNAIHD (the specific peptide inhibitor of cyclic AMP-dependent protein kinase, termed PKI) were synthesized by F Barry Caudwell on an Applied Biosystems 431A peptide synthesizer, and their concentrations were determined by quantitative amino-acid analysis. Glutathione-Sepharose was purchased from Pharmacia, alkylated trypsin and chymotrypsin from Promega. The sources of all other materials were described in [19] . Buffer A contained 50 mM Tris/HCl pH 7.5, 1 mM EDTA 1 mM EGTA, 1% (by volume) Triton X-100, 1 mM sodium orthovanadate, 10 mM sodium β-glycerophosphate, 50 mM NaF, 5 mM sodium pyrophosphate, 1 µM microcystin-LR, 0.27 M sucrose, 1 mM benzamidine, 0.2 mM phenylmethylsulphonyl fluoride (PMSF), 10 µg/ml leupeptin, 0.1% (by volume) 2-mercaptoethanol. Buffer B contained 50 mM Tris/HCl pH 7.5, 0.1 mM EGTA, and 0.1% (by volume) 2-mercaptoethanol.
Plasmid constructs
The HA tagged full-length p70α1, p70α1CT104 [14] , the Myc-tagged PDK1 in the pCMV5 vector or in the pEBG2T vector [19] , constitutively active PI 3-kinase, p110* [15] , PKB and gag-PKB [21] were as previously described. The vector pEBG [22] was modified to accommodate previously constructed p70 variants, by insertion of a new polylinker that encodes in the following order, NotI, SpeI, KpnI, ClaI, SmaI, SalI, and BamHI restriction sites. Subcloning from pMT2 into the modified pEBG involved excision of the pMT2 inserts using NotI and BamHI; the p70 variants thus transferred were full-length p70α1, p70α1CT104, p70α1CT104 (Lys123→Met), p70α1CT104 (Thr252→Ala), p70∆2-46 and p70∆2-46/∆CT104 [14] . Additional p70α1 mutants including Ser394→Ala, Ser394→Asp, Thr412→Ala, Thr412→Glu, 5 Ala (Ser434→Ala, Ser441→Ala, Thr444→Ala, Ser447→Ala, Ser452→Ala), were constructed by digestion of the pMT2 full-length p70α1 or p70α1∆CT104 plasmids with XhoI and BspMI and ligation of a XhoI/BspMI double-digested polymerase chain reaction (PCR) fragment prepared by a two-step PCR [14] . The Ala394/Glu412 and Asp394/Glu412 double mutants were generated from plasmids carrying the Ala394 and Asp394 mutations, respectively, using mutagenic oligonucleotides encoding Ala412 and Glu412. Diagnostic restriction sites were engineered into the mutants as follows: Ala394, SalI; Asp394, SalI; Ala412, BsiWI; Glu412, BstB1; 5 Ala, ApoI.
Expression of GST-p70 S6 kinase constructs
Twenty 10 cm diameter dishes of human embryonic kidney 293 cells were each transfected with 20 µg pEBG plasmid DNA encoding the p70 S6 kinase mutants described above, using a modified calcium phosphate method [19] ; 24 h after transfection, the cells were serum starved for 16 h and the cells in each dish were lysed in 1 ml ice-cold Buffer A. The 20 lysates were pooled, centrifuged at 4°C for 10 min at 13,000 g and the supernatant incubated at 4°C for 60 min on a rotating platform with 1 ml of glutathione-Sepharose previously equilibrated in Buffer A. The suspension was centrifuged for 1 min at 3000 g, the beads washed three times with 10 ml Buffer A containing 0.5 M NaCl, and then a further 10 times with 10 ml Buffer B [19] . GST-p70 S6 kinase fusion proteins were eluted from the beads at ambient temperature with three 1 ml portions of Buffer B containing 20 mM glutathione pH 8.0. The combined eluates were divided into aliquots, snap frozen in liquid nitrogen, and stored at -80°C. Between 0.5 and 2.0 mg of each GST-fusion protein was recovered at a purity of 80% or more, as judged by SDS-polyacrylamide gel electrophoresis (Figure 2 ).
Transient transfection experiments
CHO-IR cells grown in Ham's F12 medium with 10% fetal bovine serum were transfected with HA-p70 or HA-p70∆CT104 [14] alone or with p110* [15] , Myc-PDK1 in the pCMV5 vector [19] , PKB or gag-PKB [21] . Two days later, the cells were deprived of serum for 16 h, and exposed to insulin (10 -7 M) or carrier for 20 min prior to harvest. Cell extracts were prepared at 4°C, cleared by centrifugation, and aliquots matched for protein were subjected to immunoprecipitation with the anti-HA monoclonal antibody 12CA5. The immunoprecipitates were assayed for 40S kinase activity as before [14, 27] . Reactions were terminated with SDS, subjected to SDS-polyacrylamide gel electrophoresis, transfered to PVDF membranes, subjected to autoradiography and immunoblot analysis using anti-p70 antiserum [2] .
Activation of p70 S6 kinase proteins by PDK1
The assay was carried out in two stages. In the first stage, GST-p70 S6 kinase was incubated with either 9 nM or 0.9 nM PDK1 in the presence of Mg-ATP. In the second stage, Mg-[γ 32 -P]ATP, and a specific p70 peptide substrate, KKRNRTLTV were added. In stage 1, an 18 µl reaction mixture containing 50 mM Tris-HCl pH 7.4, 0.1 mM EGTA, 0.1% (by volume) 2-mercaptoethanol, 0.1 mM EGTA, 2.5 µM PKI, 1 µM microcystin-LR, 10 mM Mg(Ac) 2 , 100 µM unlabelled ATP and 0.6 µM GST-p70 S6 kinase. The assay was initiated by the addition of 2 µl of either 90 nM or 9 nM GST-PDK1 in Buffer B containing 1 mg/ml bovine serum albumin. After incubation for 30 min at 30°C, stage 2 of the assay was initiated by the addition of 30 µl of a mixture containing 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 0.1% (by volume) 2-mercaptoethanol, 0.1 mM EGTA, 2.5 µM PKI, 1 µM microcystin-LR, 10 mM Mg(Ac) 2 , 100 µM [γ-32 P]ATP (200-400 cpm/pmol), 100 µM of the peptide KKRNRTLTV. After 10 min at 30°C, the reactions were terminated by spotting the reaction mixture onto p81 phosphocellulose paper. The papers were washed in phosphoric acid and analyzed by liquid scintillation counting. A control reaction in which GST-p70 S6 kinase was omitted and taken as the blank and was always less than 5% of the activity measured in the presence of GST-p70 S6 kinase. The basal GST-p70 S6 kinase activity is the activity measured in the absence of PDK1. One unit (U) of p70 S6 kinase activity was defined as the phosphorylation of 1 nmol of the peptide KKRNRTLTV in 1 min.
Phosphorylation of GST-p70 S6 kinase by PDK1
The incubations were identical to stage 1 described above except that [γ-32 P]ATP (500-1000 c.p.m./pmol) was used instead of unlabelled ATP. The reactions were terminated by addition of SDS to 1% (by mass). The samples were subjected to SDS-polyacrylamide gel electrophoresis on a 7.5% gel; after staining with Coomassie blue, the bands corresponding to GST-p70 (detected by autoradiography) were excised and the 32 P-radioactivity associated with each band was quantified.
Mapping the site on GST-p70 S6 kinase phosphorylated by PDK1
GST-p70 S6 kinase was phosphorylated with PDK1 at a final concentration of 9 nM as above, except that the scale of the reaction was increased 10-fold. The reaction was stopped by the addition of SDS and 2-mercaptoethanol to final concentrations of 1% (by mass) and 1% (by volume), respectively, and heated for 5 min at 95°C. After cooling, 4-vinylpyridine was added to a concentration of 2.5% (by volume) and the sample was shaken for 1 h at 30°C, subjected to electophoresis on a 7.5% SDS-polyacrylamide gel and the 83 kDa 32 Plabelled band corresponding to GST-p70 S6 kinase was excised. After extraction into SDS, the protein was precipitated with trichloroacetic acid, washed extensively, and digested at 30°C in 0.3 ml of 50 mM Tris-HCl pH 8.0, 0.1% (by volume) Triton-X100 containing 2 µg alkylated trypsin. After 16 h, guanidinium hydrochloride was added on ice to a final concentration to 1.0 M; after centrifugation, the supernatants, containing 90% of the 32 P-radioactivity, were chromatographed on a Vydac C 18 column as described in the legend to Figure 5 .
